We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.
- Authors
Yamaguchi, Motoko; Kwong, Yok-Lam; Kim, Won Seog; Maeda, Yoshinobu; Hashimoto, Chizuko; Suh, Cheolwon; Izutsu, Koji; Ishida, Fumihiro; Isobe, Yasushi; Sueoka, Eisaburo; Suzumiya, Junji; Kodama, Takao; Kimura, Hiroshi; Hyo, Rie; Nakamura, Shigeo; Oshimi, Kazuo; Suzuki, Ritsuro
- Abstract
To explore a more effective treatment for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type (ENKL), we conducted a phase II study of the steroid (dexamethasone), methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) regimen.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Vol 29, Issue 33, p4410
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2011.35.6287